ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$20.61

Market cap

$9.77B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$15.56B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
The quick ratio has grown by 44% YoY and by 16% from the previous quarter
The company's EPS rose by 41% YoY and by 24% QoQ
ELAN's equity is down by 4.9% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: OCUP

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
474.1M
Market cap
$9.77B
Enterprise value
$15.56B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.28
Price to sales (P/S)
2.12
EV/EBIT
N/A
EV/EBITDA
31.06
EV/Sales
3.28
Earnings
Revenue
$4.75B
EBIT
-$189M
EBITDA
$501M
Free cash flow
$254M
Per share
EPS
-$0.74
Free cash flow per share
$0.52
Book value per share
$16.09
Revenue per share
$9.73
TBVPS
$9.71
Balance sheet
Total assets
$16.25B
Total liabilities
$8.64B
Debt
$6.13B
Equity
$7.61B
Working capital
$1.89B
Liquidity
Debt to equity
0.81
Current ratio
2.44
Quick ratio
1.17
Net debt/EBITDA
11.56
Margins
EBITDA margin
10.6%
Gross margin
56.3%
Net margin
-7.6%
Operating margin
-4%
Efficiency
Return on assets
-2.2%
Return on equity
-4.7%
Return on invested capital
-2.1%
Return on capital employed
-1.3%
Return on sales
-4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
3.36%
1 week
0.29%
1 month
-11.05%
1 year
-41.1%
YTD
-27.38%
QTD
-21%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.75B
Gross profit
$2.67B
Operating income
-$189M
Net income
-$363M
Gross margin
56.3%
Net margin
-7.6%
The company's operating margin has surged by 69% YoY and by 42% QoQ
Elanco Animal Health's operating income has soared by 61% YoY and by 43% from the previous quarter
The net margin is up by 49% year-on-year and by 23% since the previous quarter
Elanco Animal Health's net income has increased by 37% YoY and by 23% from the previous quarter

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.28
P/S
2.12
EV/EBIT
N/A
EV/EBITDA
31.06
EV/Sales
3.28
The company's EPS rose by 41% YoY and by 24% QoQ
The price to book (P/B) is 35% lower than the last 4 quarters average of 1.9
ELAN's equity is down by 4.9% YoY
ELAN's P/S is 34% below its last 4 quarters average of 3.1
Elanco Animal Health's revenue has increased by 23% YoY

Efficiency

How efficient is Elanco Animal Health business performance
The company's return on sales has surged by 69% YoY and by 42% QoQ
Elanco Animal Health's ROIC has soared by 68% YoY and by 45% from the previous quarter
The company's return on assets rose by 41% YoY and by 21% QoQ
Elanco Animal Health's ROE has increased by 36% YoY and by 22% from the previous quarter

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 88% higher than its total liabilities
Elanco Animal Health's current ratio has increased by 49% YoY and by 23% from the previous quarter
The quick ratio has grown by 44% YoY and by 16% from the previous quarter
The debt is 19% smaller than the equity
The debt to equity has increased by 5% year-on-year but it has declined by 3.6% since the previous quarter
ELAN's equity is down by 4.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.